Non-alcoholic fatty liver disease (NAFLD)–pathogenesis, classification, and effect on drug metabolizing enzymes and transporters E Cobbina, F Akhlaghi Drug metabolism reviews 49 (2), 197-211, 2017 | 628 | 2017 |
Anti-influenza prodrug oseltamivir is activated by carboxylesterase human carboxylesterase 1, and the activation is inhibited by antiplatelet agent clopidogrel D Shi, J Yang, D Yang, EL LeCluyse, C Black, L You, F Akhlaghi, B Yan Journal of Pharmacology and Experimental Therapeutics 319 (3), 1477-1484, 2006 | 285 | 2006 |
Oxytocin by intranasal and intravenous routes reaches the cerebrospinal fluid in rhesus macaques: determination using a novel oxytocin assay MR Lee, KB Scheidweiler, XX Diao, F Akhlaghi, A Cummins, MA Huestis, ... Molecular psychiatry 23 (1), 115-122, 2018 | 237 | 2018 |
Secondary Metabolites Produced by the Marine Bacterium Halobacillus salinus That Inhibit Quorum Sensing-Controlled Phenotypes in Gram-Negative Bacteria ME Teasdale, J Liu, J Wallace, F Akhlaghi, DC Rowley Applied and environmental microbiology 75 (3), 567-572, 2009 | 234 | 2009 |
Distribution of cyclosporin in organ transplant recipients F Akhlaghi, AK Trull Clinical pharmacokinetics 41, 615-637, 2002 | 171 | 2002 |
Effect of diabetes mellitus on pharmacokinetic and pharmacodynamic properties of drugs M Dostalek, F Akhlaghi, M Puzanovova Clinical pharmacokinetics 51, 481-499, 2012 | 158 | 2012 |
Significantly reduced cytochrome P450 3A4 expression and activity in liver from humans with diabetes mellitus M Dostalek, MH Court, B Yan, F Akhlaghi British journal of pharmacology 163 (5), 937-947, 2011 | 144 | 2011 |
Insulin resistance, ceramide accumulation, and endoplasmic reticulum stress in human chronic alcohol‐related liver disease L Longato, K Ripp, M Setshedi, M Dostalek, F Akhlaghi, M Branda, ... Oxidative medicine and cellular longevity 2012 (1), 479348, 2012 | 138 | 2012 |
A comparative pH-dissolution profile study of selected commercial levothyroxine products using inductively coupled plasma mass spectrometry D Pabla, F Akhlaghi, H Zia European journal of pharmaceutics and biopharmaceutics 72 (1), 105-110, 2009 | 138 | 2009 |
Physicochemical properties, biotransformation, and transport pathways of established and newly approved medications: a systematic review of the top 200 most prescribed drugs vs … A Saravanakumar, A Sadighi, R Ryu, F Akhlaghi Clinical pharmacokinetics 58, 1281-1294, 2019 | 119 | 2019 |
Nonalcoholic fatty liver disease and diabetes are associated with decreased CYP3A4 protein expression and activity in human liver R Jamwal, SM De La Monte, K Ogasawara, S Adusumalli, BB Barlock, ... Molecular pharmaceutics 15 (7), 2621-2632, 2018 | 114 | 2018 |
The novel ghrelin receptor inverse agonist PF-5190457 administered with alcohol: preclinical safety experiments and a phase 1b human laboratory study MR Lee, JD Tapocik, M Ghareeb, ML Schwandt, AA Dias, AN Le, ... Molecular psychiatry 25 (2), 461-475, 2020 | 107 | 2020 |
Development of a sensitive and selective method for the quantitative analysis of cortisol, cortisone, prednisolone and prednisone in human plasma IA Ionita, DM Fast, F Akhlaghi Journal of Chromatography B 877 (8-9), 765-772, 2009 | 100 | 2009 |
Future of cholesteryl ester transfer protein (CETP) inhibitors: a pharmacological perspective AH Mohammadpour, F Akhlaghi Clinical pharmacokinetics 52, 615-626, 2013 | 93 | 2013 |
Declining intracellular T-lymphocyte concentration of cyclosporine a precedes acute rejection in kidney transplant recipients P Falck, A Åsberg, H Guldseth, S Bremer, F Akhlaghi, JLE Reubsaet, ... Transplantation 85 (2), 179-184, 2008 | 93 | 2008 |
Multidrug Resistance-Associated Protein 2 (MRP2/ABCC2) Haplotypes Significantly Affect the Pharmacokinetics of Tacrolimus in Kidney Transplant Recipients K Ogasawara, SD Chitnis, RY Gohh, U Christians, F Akhlaghi Clinical pharmacokinetics 52, 751-762, 2013 | 90 | 2013 |
Population pharmacokinetic estimation of tacrolimus apparent clearance in adult liver transplant recipients H Zahir, AJ McLachlan, A Nelson, G McCaughan, M Gleeson, F Akhlaghi Therapeutic drug monitoring 27 (4), 422-430, 2005 | 78 | 2005 |
High-performance liquid chromatography method for the determination of mycophenolic acid and its acyl and phenol glucuronide metabolites in human plasma CG Patel, F Akhlaghi Therapeutic drug monitoring 28 (1), 116-122, 2006 | 69 | 2006 |
Determination of total mycophenolic acid and its glucuronide metabolite using liquid chromatography with ultraviolet detection and unbound mycophenolic acid using tandem mass … CG Patel, AE Mendonza, F Akhlaghi, O Majid, AK Trull, T Lee, DW Holt Journal of Chromatography B 813 (1-2), 287-294, 2004 | 68 | 2004 |
Intestinal permeability enhancement of levothyroxine sodium by straight chain fatty acids studied in MDCK epithelial cell line D Pabla, F Akhlaghi, H Zia European journal of pharmaceutical sciences 40 (5), 466-472, 2010 | 62 | 2010 |